临床实验-话题@MedSci - 梅斯（MedSci）

#临床实验#

34篇内容 | 1535人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1941550, encodeId=d5461941550ee, content=<a href='/topic/show?id=108022e76b3' target=_blank style='color:#2F92EE;'>#临床实验#</a>, objectTitle=CCLM：含水量在临床实验室中的假低钠血症患病率检测中的作用, objectType=article, longId=98803, objectId=565a98803c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=565a98803c2, replyNumber=0, likeNumber=65, createdTime=2017-10-26, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=565a98803c2, moduleTitle=CCLM：含水量在临床实验室中的假低钠血症患病率检测中的作用, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=565a98803c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941553, encodeId=5485194155310, content=<a href='/topic/show?id=108022e76b3' target=_blank style='color:#2F92EE;'>#临床实验#</a>, objectTitle=CCLM：根据ISO 15189验证临床实验室检查程序的不**性，真实性和诊断准确度, objectType=article, longId=111598, objectId=a557111598cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a557111598cf, replyNumber=0, likeNumber=0, createdTime=2018-05-04, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a557111598cf, moduleTitle=CCLM：根据ISO 15189验证临床实验室检查程序的不**性，真实性和诊断准确度, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a557111598cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941555, encodeId=830c1941555f3, content=<a href='/topic/show?id=108022e76b3' target=_blank style='color:#2F92EE;'>#临床实验#</a>, objectTitle=美新临床实验政策引担忧, objectType=article, longId=127944, objectId=085212e94492, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=085212e94492, replyNumber=0, likeNumber=59, createdTime=2018-11-12, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=085212e94492, moduleTitle=美新临床实验政策引担忧, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=085212e94492)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941549, encodeId=3dd119415490d, content=<a href='/topic/show?id=108022e76b3' target=_blank style='color:#2F92EE;'>#临床实验#</a>, objectTitle=重磅！Nat Med报道HIV抗体临床实验获得成功, objectType=article, longId=87894, objectId=88818e894e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88818e894e6, replyNumber=0, likeNumber=72, createdTime=2017-04-25, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88818e894e6, moduleTitle=重磅！Nat Med报道HIV抗体临床实验获得成功, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=88818e894e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941552, encodeId=af451941552f5, content=<a href='/topic/show?id=108022e76b3' target=_blank style='color:#2F92EE;'>#临床实验#</a>, objectTitle=美精神研究机构削减临床实验, objectType=article, longId=102694, objectId=94f9102694f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=94f9102694f5, replyNumber=0, likeNumber=61, createdTime=2018-03-24, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=94f9102694f5, moduleTitle=美精神研究机构削减临床实验, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=94f9102694f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941547, encodeId=f726194154e5d, content=<a href='/topic/show?id=108022e76b3' target=_blank style='color:#2F92EE;'>#临床实验#</a>, objectTitle=仅3.57%的临床实验室自己确定甲功参考区间, objectType=article, longId=68559, objectId=fb0668559a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb0668559a5, replyNumber=0, likeNumber=71, createdTime=2016-10-02, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb0668559a5, moduleTitle=仅3.57%的临床实验室自己确定甲功参考区间, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=fb0668559a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941548, encodeId=dee9194154807, content=<a href='/topic/show?id=108022e76b3' target=_blank style='color:#2F92EE;'>#临床实验#</a>, objectTitle=两大重挫：Juno又停止JCAR015 CAR-T临床实验，礼来阿尔兹海默病药物临床III期失败, objectType=article, longId=83111, objectId=9909831112d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9909831112d, replyNumber=0, likeNumber=75, createdTime=2017-04-18, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9909831112d, moduleTitle=两大重挫：Juno又停止JCAR015 CAR-T临床实验，礼来阿尔兹海默病药物临床III期失败, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9909831112d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941545, encodeId=435b1941545eb, content=<a href='/topic/show?id=108022e76b3' target=_blank style='color:#2F92EE;'>#临床实验#</a>, objectTitle=关注：法国临床实验事故原因推测, objectType=article, longId=63196, objectId=c0d363196be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0d363196be, replyNumber=0, likeNumber=67, createdTime=2016-11-08, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0d363196be, moduleTitle=关注：法国临床实验事故原因推测, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c0d363196be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941546, encodeId=f0ca1941546e1, content=<a href='/topic/show?id=108022e76b3' target=_blank style='color:#2F92EE;'>#临床实验#</a>, objectTitle=临床实验室自建项目（LDT）的过去、现在、未来, objectType=article, longId=68103, objectId=fda46810328, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fda46810328, replyNumber=0, likeNumber=75, createdTime=2016-07-30, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fda46810328, moduleTitle=临床实验室自建项目（LDT）的过去、现在、未来, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=fda46810328)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941544, encodeId=8126194154436, content=<a href='/topic/show?id=108022e76b3' target=_blank style='color:#2F92EE;'>#临床实验#</a>, objectTitle=Eur Heart J：股动脉路径与桡动脉路径行PCI对预后的影响——CHAMPION PHOENIX临床实验, objectType=article, longId=56786, objectId=207a56e8680, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=207a56e8680, replyNumber=0, likeNumber=0, createdTime=2016-03-14, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=207a56e8680, moduleTitle=Eur Heart J：股动脉路径与桡动脉路径行PCI对预后的影响——CHAMPION PHOENIX临床实验, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=207a56e8680)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941543, encodeId=ce7719415432c, content=<a href='/topic/show?id=108022e76b3' target=_blank style='color:#2F92EE;'>#临床实验#</a>, objectTitle=NIPT试点：发展临床实验室是必经之路, objectType=article, longId=46164, objectId=facc4616416, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=facc4616416, replyNumber=0, likeNumber=73, createdTime=2015-02-06, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=facc4616416, moduleTitle=NIPT试点：发展临床实验室是必经之路, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=facc4616416)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941541, encodeId=9d501941541f3, content=<a href='/topic/show?id=108022e76b3' target=_blank style='color:#2F92EE;'>#临床实验#</a>, objectTitle=葛兰素史克生产的埃博拉病毒疫苗将在美国开始临床实验, objectType=article, longId=39743, objectId=edbf39e43fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=edbf39e43fd, replyNumber=0, likeNumber=62, createdTime=2015-07-27, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=edbf39e43fd, moduleTitle=葛兰素史克生产的埃博拉病毒疫苗将在美国开始临床实验, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=edbf39e43fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941542, encodeId=35c0194154296, content=<a href='/topic/show?id=108022e76b3' target=_blank style='color:#2F92EE;'>#临床实验#</a>, objectTitle=研究型医院：提高转化医学与临床实验的研究水平, objectType=article, longId=40735, objectId=022340e3532, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=022340e3532, replyNumber=0, likeNumber=76, createdTime=2015-01-25, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=022340e3532, moduleTitle=研究型医院：提高转化医学与临床实验的研究水平, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=022340e3532)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941540, encodeId=531b1941540fb, content=<a href='/topic/show?id=108022e76b3' target=_blank style='color:#2F92EE;'>#临床实验#</a>, objectTitle=N Engl J Med：利那洛肽治慢性便秘完成Ⅲ期临床实验, objectType=article, longId=3691, objectId=9f593691cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f593691cb, replyNumber=0, likeNumber=65, createdTime=2012-02-06, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f593691cb, moduleTitle=N Engl J Med：利那洛肽治慢性便秘完成Ⅲ期临床实验, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9f593691cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

临床实验

2020-05-29

liuhuangbo (审核中...)

前往app查看评论内容

#临床实验#

CCLM：含水量在临床实验室中的假低钠血症患病率检测中的作用

2017-10-26

liuhuangbo (审核中...)

前往app查看评论内容

#临床实验#

CCLM：根据ISO 15189验证临床实验室检查程序的不**性，真实性和诊断准确度

2018-05-04

liuhuangbo (审核中...)

前往app查看评论内容

#临床实验#

美新临床实验政策引担忧

2018-11-12

liuhuangbo (审核中...)

前往app查看评论内容

#临床实验#

重磅！Nat Med报道HIV抗体临床实验获得成功

2017-04-25

liuhuangbo (审核中...)

前往app查看评论内容

#临床实验#

美精神研究机构削减临床实验

2018-03-24

liuhuangbo (审核中...)

前往app查看评论内容

#临床实验#

仅3.57%的临床实验室自己确定甲功参考区间

2016-10-02

liuhuangbo (审核中...)

前往app查看评论内容

#临床实验#

两大重挫：Juno又停止JCAR015 CAR-T临床实验，礼来阿尔兹海默病药物临床III期失败

2017-04-18

liuhuangbo (审核中...)

前往app查看评论内容

#临床实验#

关注：法国临床实验事故原因推测

2016-11-08

liuhuangbo (审核中...)

前往app查看评论内容

#临床实验#

临床实验室自建项目（LDT）的过去、现在、未来

2016-07-30

liuhuangbo (审核中...)

前往app查看评论内容

#临床实验#

Eur Heart J：股动脉路径与桡动脉路径行PCI对预后的影响——CHAMPION PHOENIX临床实验

2016-03-14

liuhuangbo (审核中...)

前往app查看评论内容

#临床实验#

NIPT试点：发展临床实验室是必经之路

2015-02-06

liuhuangbo (审核中...)

前往app查看评论内容

#临床实验#

葛兰素史克生产的埃博拉病毒疫苗将在美国开始临床实验

2015-07-27

liuhuangbo (审核中...)

前往app查看评论内容

#临床实验#

研究型医院：提高转化医学与临床实验的研究水平

2015-01-25

liuhuangbo (审核中...)

前往app查看评论内容

#临床实验#

N Engl J Med：利那洛肽治慢性便秘完成Ⅲ期临床实验

2012-02-06

科室
- - 订阅+
  - 更多科室
工具
服务